Correlation Between Procter Gamble and WuXi Biologics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Procter Gamble and WuXi Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Procter Gamble and WuXi Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Procter Gamble and WuXi Biologics, you can compare the effects of market volatilities on Procter Gamble and WuXi Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Procter Gamble with a short position of WuXi Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Procter Gamble and WuXi Biologics.

Diversification Opportunities for Procter Gamble and WuXi Biologics

-0.55
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Procter and WuXi is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding Procter Gamble and WuXi Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on WuXi Biologics and Procter Gamble is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Procter Gamble are associated (or correlated) with WuXi Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of WuXi Biologics has no effect on the direction of Procter Gamble i.e., Procter Gamble and WuXi Biologics go up and down completely randomly.

Pair Corralation between Procter Gamble and WuXi Biologics

Allowing for the 90-day total investment horizon Procter Gamble is expected to generate 0.18 times more return on investment than WuXi Biologics. However, Procter Gamble is 5.47 times less risky than WuXi Biologics. It trades about 0.09 of its potential returns per unit of risk. WuXi Biologics is currently generating about -0.04 per unit of risk. If you would invest  14,038  in Procter Gamble on September 4, 2024 and sell it today you would earn a total of  3,932  from holding Procter Gamble or generate 28.01% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Procter Gamble  vs.  WuXi Biologics

 Performance 
       Timeline  
Procter Gamble 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Procter Gamble are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable technical and fundamental indicators, Procter Gamble is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.
WuXi Biologics 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in WuXi Biologics are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite nearly inconsistent fundamental drivers, WuXi Biologics reported solid returns over the last few months and may actually be approaching a breakup point.

Procter Gamble and WuXi Biologics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Procter Gamble and WuXi Biologics

The main advantage of trading using opposite Procter Gamble and WuXi Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Procter Gamble position performs unexpectedly, WuXi Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in WuXi Biologics will offset losses from the drop in WuXi Biologics' long position.
The idea behind Procter Gamble and WuXi Biologics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Other Complementary Tools

My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency